http://www.medpagetoday.com/ProductAlert/Prescriptions/13064Newly unsealed court documents suggest that AstraZeneca tried to minimize the risk of diabetes and weight gain associated with its antipsychotic drug quetiapine (Seroquel), in part by "cherry-picking" data for publication.
The documents emerged during a trial consolidating lawsuits filed against AstraZeneca by some 9,000 people who claim to have developed diabetes while taking the drug. In the case, being heard here in federal court, the plaintiffs claim they were not adequately informed of the drug's risk.
-long snip full of details-
Additional documents in the case remain sealed. Plaintiffs' lawyers as well as the Bloomberg news organization have requested that they be made public as well.
------------------------
take antipsychotic drug get diabetes - what fun - then the drug barons can get you to over pay for two illnesses.